Tongjitang prices US IPO 33% below initial price range

The Chinese medicine maker becomes the first Mainland company to cut the size of a US offering this year as the fall-out from the equity market correction broadens.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition